• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Leucine-rich repeat-containing protein 52 (LRRC52), Truncated

ACP14882

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP14882 Target NameLRRC52
Target SynonymsLRRC52; Leucine-rich repeat-containing protein 52; BK channel auxiliary gamma subunit LRRC52FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8N7C0
Background Information
  • Uniprot Id

    Q8N7C0

  • Target Species

    Human

  • Target Name

    LRRC52

  • Target Full Name

    Leucine-rich repeat-containing protein 52

  • Target Function

    Auxiliary protein of the large-conductance, voltage and calcium-activated potassium channel (BK alpha). Modulates gating properties by producing a marked shift in the BK channel's voltage dependence of activation in the hyperpolarizing direction, and in the absence of calcium. KCNU1 channel auxiliary protein. May modulate KCNU1 gating properties.

  • Target Subcellular Location

    Cell membrane; Single-pass membrane protein. Note=Expression at the cell surface may require the presence of KCNU1.

  • Target Tissue Specificity

    Mainly expressed in testis and skeletal muscle.

  • Target Synonyms

    LRRC52; Leucine-rich repeat-containing protein 52; BK channel auxiliary gamma subunit LRRC52

Inquire Recombinant Human Leucine-rich repeat-containing protein 52 (LRRC52), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification